Cigna (CI) Q2 Earnings Highlight Dividend Sustainability Amid Mixed Insider Activity

On July 30, 2026, Cigna (NYSE: CI) reported second-quarter results that beat expectations and raised its full-year adjusted income guidance. The healthcare giant’s latest financials and proprietary metrics reveal a dividend profile worth watching for income-focused investors.

• Cigna offers a dividend yield of 2.07% with a low payout ratio of 20% and a solid 3-year dividend growth rate of 10.5%, supporting a sustainable and attractive income stream according to its GF Value™ verdict.
• The company’s GF Score™ stands at 51 out of 100, reflecting moderate overall health with strengths in profitability and financial strength but weaknesses in valuation and momentum.
• Insider activity shows no insider buying in the past three months, with insiders selling $59.4 million worth of shares, while 23 premium gurus hold CI shares—12 adding and 10 trimming recently—indicating mixed but engaged institutional interest.

What's Behind the News?

Cigna’s Q2 2026 earnings announcement showcased a non-GAAP EPS of $7.78, beating estimates by $0.18, alongside revenues of $71.7 billion, which surpassed forecasts by $1.52 billion and grew 6.7% year-over-year. The company also raised its fiscal 2026 adjusted income guidance to at least $30.45 per share, up $0.10 from prior estimates. This positive revision signals management’s confidence in sustained operational performance, driven by strong contributions from Evernorth and Cigna Healthcare segments.

As a leading healthcare services provider, The Cigna Group operates primarily in the healthcare plans industry within the broader healthcare sector. With a market capitalization of $78.43 billion, CI offers pharmacy benefit management and health insurance services, including specialty pharmacy solutions expanded through its 2018 merger with Express Scripts. The company serves roughly 18 million medical members globally, predominantly in the U.S., and maintains key contracts such as with the Department of Defense and Centene.

Is CI's Dividend Safe and Attractive?

Cigna’s dividend profile stands out for income investors seeking both yield and growth. The current dividend yield of 2.07% is modest but complemented by a conservative payout ratio of just 20%, indicating ample room for dividend sustainability even if earnings fluctuate. Moreover, the company has delivered a healthy 10.5% average dividend growth over the past three years, underscoring management’s commitment to returning capital to shareholders while balancing reinvestment needs.

Supporting this positive dividend thesis, Cigna’s GF Value™ verdict shows the stock is fairly valued relative to its intrinsic worth, though no explicit undervaluation is indicated. Investors can explore the detailed GF Value™ analysis for CI here. This alignment between valuation and dividend fundamentals suggests that income-oriented investors may find Cigna’s payout both safe and reasonably priced in the current market environment.

What Does CI's GF Score™ Tell Us?

The GF Score™ aggregates multiple financial dimensions—such as profitability, growth, financial strength, valuation, and momentum—to provide a comprehensive health snapshot of a company. Cigna’s overall GF Score™ of 51/100 indicates a moderate standing, with notable strengths and areas for improvement.

Cigna’s strongest areas are profitability and financial strength, reflecting solid earnings quality and a stable balance sheet. However, the low valuation and momentum ranks highlight challenges such as a price-to-earnings ratio near historical medians but limited recent price appreciation and some insider selling pressure. For a deeper dive, visit Cigna’s stock page.

What Are Gurus and Insiders Doing with CI?

Institutional guru ownership remains robust, with 23 premium gurus holding CI shares. In recent quarters, 12 gurus have increased their positions while 10 have trimmed, reflecting a balanced but engaged institutional interest in the company. This nuanced guru activity provides a valuable signal beyond typical analyst coverage, as GuruFocus uniquely tracks these 13F filings.

Conversely, insider activity over the past three months shows no insider purchases but $59.4 million in insider selling across two transactions. While insider selling can sometimes raise caution flags, it is not uncommon in large-cap stocks and should be weighed alongside other fundamentals and institutional trends.

What This Means for Investors

For investors prioritizing dividend sustainability, Cigna presents a compelling case with its moderate yield, low payout ratio, and consistent dividend growth. The company’s solid financial strength and profitability underpin the safety of its payout, even as valuation and momentum metrics suggest limited near-term upside in share price. The mixed signals from insider selling and guru ownership emphasize the importance of monitoring ongoing institutional sentiment. Overall, Cigna’s dividend profile combined with its GF Score™ and GF Value™ metrics make it a noteworthy candidate for income-focused portfolios. For further details, explore the CI stock page or use the GuruFocus Stock Screener to compare with peers.

Frequently Asked Questions

What is CI's GF Score™?

CI’s GF Score™ of 51 out of 100 reflects a moderate overall financial health, with particular strengths in profitability and financial strength, but weaknesses in valuation and momentum.

Is CI's dividend safe?

Yes, with a dividend yield of 2.07%, a low payout ratio of 20%, and a 3-year dividend growth rate of 10.5%, Cigna’s dividend appears both safe and attractive for income investors.

What is CI's P/E ratio compared to historical?

CI’s trailing P/E ratio is 12.57x, slightly below its 5-year median P/E of 12.93x, indicating the stock is valued near its historical average.